LSD acetate is a polypeptide that specifically targets C8161 melanoma lymphatic vessels without binding to normal lymphatic vessels or tumor blood vessels. When conjugated with pro-apoptotic peptides, LSD acetate can reduce the number of tumor lymphatic vessels. It is useful in research focused on targeted therapy and diagnostics for tumor lymphatic vessels.